Delisting riskPopularity #4,397
Gaxos.ai (GXAI)
Builds consumer AI applications and non-clinical telehealth administration services.
$0.6096
After hours+0.03 (+5.07%)
At close$0.5802(−3.94%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | 4 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | 4 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 0 |
| General & administrative | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −3 | −2 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −2 | 0 |
| Net income from continuing operations | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −2 | 0 |
| Net income | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −2 | 0 |
| EPS, basic | −$0.85 | −$0.80 | −$0.91 | −$0.72 | −$0.61 | −$0.12 | −$0.17 | −$0.11 | −$0.14 | −$0.13 | −$0.25 | $0.02 |
| EPS, diluted | −$0.85 | −$0.80 | −$0.91 | −$0.72 | −$0.61 | −$0.12 | −$0.17 | −$0.11 | −$0.14 | −$0.13 | −$0.25 | $0.02 |
| Weighted average shares, basic | 1 | 1 | 1 | 1 | 1 | 7 | 7 | 7 | 7 | 7 | 9 | 10 |
| Weighted average shares, diluted | 1 | 1 | 1 | 1 | 1 | 7 | 7 | 7 | 7 | 7 | 9 | 10 |
| EBITDA | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −2 | −2 | −2 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −2 | −2 | −2 |